Collaboration between the
public academy and pharmaceuticals

Supported by the Innovative Medicines Initiative (IMI)


Research for the development of
precision medicine strategies


Investigating systemic
autoimmune diseases…

Systemic lupus erythematosus, systemic sclerosis, Sjögren’s syndrome,
rheumatoid arthritis, primary antiphospholipid syndrome , mixed connective tissue disease

  • Welcome to PRECISESADS

    PRECISESADS is an EU project formed by 21 academic, 2 SMEs and 5 industrial partners from 12 countries spread right across Europe, planned for 5 years with a budg...
    Read more
  • UPDATE! News & Events

    TAXONOMY Joint Legal Meeting
    PRECISESADS & AETIONOMY Consortiums met in Berlin at Bayer to discuss legal and ethical issues

    Read more
  • PRECISESADS Partner profile

    QBIO is a Swiss service and consulting company specialized in the computational analysis of biomarker data from clinical trials.
    Read more

About PRECISESADS

Inflammatory autoimmune diseases such as rheumatoid arthritis and lupus affect 1-3% of the population, and while treatments exist, these are costly and have a number of serious side effects. There is growing evidence that many of these conditions may be incorrectly classified. The PRECISESADS project will study 2 500 people with various autoimmune diseases, gathering data on the molecular causes of their disease as well as their clinical symptoms. Using this information, they will pave the way for a new classification of these diseases, something that will allow doctors to offer patients more personalised treatments at an earlier stage of their disease.

IMI PRECISESADS, Bayer Pharma

Latest Project News

    • 05 APR 17
    • 0
    PRECISESADS Datahon Training and General Assembly in Paris, 7-10th of March 2017

    PRECISESADS Datahon Training and General Assembly in Paris, 7-10th of March 2017

    The latest PRECISESADS meeting took place on the 7-10th of March 2017 at SERVIER`s headquarters in PARIS. This 4 days event started with the Datathon training, organised by Jérôme Wojcik (WP8), that had as a main objective to perform clustering analyses of Cross-Sectional phase 1 data, allowing different partners to work together and exchange code

    • 22 SEP 16
    • 0
    PRECISESADS hits 2 000 mark on patient recruitment

    PRECISESADS hits 2 000 mark on patient recruitment

    PRECISESADS http://www.precisesads.eu/, an IMI funded project, has now recruited over 2 000 people into its pan-European clinical study on systemic autoimmune diseases such as rheumatoid arthritis and lupus. This milestone means that the project is well on track towards its final goal of recruiting a total of 2 500 people from across 9 different countries.

Events

    • 25/04/2017
      Berlin, Germany
    IMG_0004

    TAXONOMY Joint Legal Meeting

    On 25th April, selected colleagues from both the IMI Taxonomy Call Consortiums, PRECISESADS & AETIONOMY, met in Berlin at Bayer…

    • 03/11/2017
    ACR 2017

    ACR/ARHP Annual Meeting 2017.

    To take place in San Diego. More information

    • 14/06/2017
      Madrid
    Eular 2017

    EULAR 2017

    The next EULAR Annual European Congress of Rheumatology will take place from 14-17 June 2017 in Madrid, Spain. See more…

  • Information for Patients & Patients Associations

    General information, list of patients associations, …

Project partners